Literature DB >> 138362

Prevalence of hepatitis B infection among residents of an institution for the mentally retarded.

R K Chaudhary, E Perry, T E Cleary.   

Abstract

Data on prevalence of antibody to hepatitis B surface antigen (anti-HBs) and of hepatitis B surface antigen (HBsAg) among 95 matched pairs of Down's syndrome (DS) and other mentally retarded (OMR) patients in an institution were analyzed by age on admission and by length of residence. Passive hemagglutination test were used to determine anti-HBs. Anti-HBs prevalence increased with admission age among DS patients (26%, 42% and 56% for age groups less than or equal to 5, 6-15 and greater than 15 years, respectively) but decreased among OMR patients (85%, 71% and 78%), giving overall rates of 38% for DS and 77% for OMR which are significantly different (p less than .001). Anti-HBs prevalence increased with length of residence for OMR patients but was unchanged for DS patients. For both groups, the prevalence of hepatitis B (HB) infection (both anti-HBs and HBsAg) increased with length of residence and, overall, was nearly the same for DS and OMR patients. These observations are consistent with the hypothesis that, with respect to response to HB virus, younger DS patients are immunologically immature.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 138362     DOI: 10.1093/oxfordjournals.aje.a112363

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  Prevalence and incidence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among personnel and patients of a psychiatric hospital.

Authors:  V Di Nardo; N Petrosillo; G Ippolito; M E Bonaventura; V Puro; B Chiaretti; M Tosoni
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

2.  Prevalence of serologic markers of hepatitis B in a New Brunswick institution for the mentally retarded.

Authors:  J D Farley; B C Balram; D Margison; R K Chaudhary
Journal:  CMAJ       Date:  1987-07-01       Impact factor: 8.262

3.  Hepatitis B and Down's syndrome.

Authors:  J Green
Journal:  BMJ       Date:  1988-11-19

4.  Down syndrome and autoimmune chronic active hepatitis: satisfactory outcome with therapy.

Authors:  D O'Mahony; M J Whelton; J Hogan
Journal:  Ir J Med Sci       Date:  1990-01       Impact factor: 1.568

5.  Low prevalence of hepatitis B infections among residents of an institution for the mentally retarded in New Mexico.

Authors:  J M Mann; C J Babb; H F Hull; F D Ball; G W Brown; R S Steece
Journal:  West J Med       Date:  1984-09

6.  Deinstitutionalized mentally retarded hepatitis-B surface antigen carriers in public school classes: a descriptive study.

Authors:  C W Bakal; J S Marr; L F Novick; E S Millner; W D Goldman; O E Pitkin
Journal:  Am J Public Health       Date:  1980-07       Impact factor: 9.308

7.  Mentally retarded hepatitis-B surface antigen carriers in NYC public school classes: a public health dilemma.

Authors:  C W Bakal; L F Novick; J S Marr; E S Millner; W D Goldman; O Pitkin
Journal:  Am J Public Health       Date:  1980-07       Impact factor: 9.308

8.  Prevalence of anti-HCV in institutionalised mentally handicapped subjects.

Authors:  F Pregliasco; A Conti
Journal:  Eur J Epidemiol       Date:  1994-02       Impact factor: 8.082

9.  The prevalence of serological markers, hepatitis B virus DNA and elevated serum amino transferase values in institutionalized mentally handicapped males and females: an epidemiological study of HBV infection in residents with Down's syndrome or other forms of mental deficiency.

Authors:  T J van Ditzhuijsen; F M Kleijnen; P J Rijntjes; A M van Loon; S H Yap
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

10.  Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.

Authors:  J Hayashi; A Noguchi; K Nakashima; M Morofuji; S Kashiwagi
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.